Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

NHS programme helps cut people’s risk of developing diabetes by 20%

NHS programme helps cut people’s risk of developing diabetes by 20%

Patients who had been referred to the programme were less likely to have type 2 diabetes

The NHS Diabetes Prevention Programme, which was introduced in England in 2016, is helping hundreds of thousands of people to lead healthier lives.


People with pre-diabetes are being identified and offered a nine-month behaviour change programme that supports healthier diet and exercise choices to reduce their risk of developing diabetes.

A study funded by the National Institute for Health and Care Research (NIHR) has found a significant reduction in diabetes risk among patients who had been referred to the NHS programme.

Three years after their referral, the participants were 20 per cent less likely to have type 2 diabetes than a similar person who was not included in the programme, the evaluation revealed.

Known as the Diabetes Prevention - Long Term Multimethod Assessment (DIPLOMA) research programme, the study was led by researchers from The University of Manchester, in collaboration with The University of Sheffield, University College London and patient contributors, and supported by the NIHR Clinical Research Network.

The findings supported the decision to continue the diabetes prevention programme, increase the number of places and promote the online version.

DIPLOMA’s lead researcher, Matt Sutton said: “While half of the people referred to the programme eventually joined it, we made recommendations to improve uptake among particular groups, such as those of working age, younger adults and minority ethnic groups, and we highlighted the need to ensure the programme content stayed true to the evidence base”.

The study received £2.75 million funding from the NIHR Health and Social Care Delivery Research Programme.

According to the NHIR, more than two million people have been diagnosed with pre-diabetes in England. These people have high blood sugar levels and are more likely to develop type 2 diabetes in the future.

Making positive changes to lifestyle choices can help these patients reduce the risk of developing type 2 diabetes and prevent complications, such as heart disease, kidney problems and nerve damage, it added.

More For You

St James's University Hospital , NHS

Care Quality Commission downgraded the maternity and neonatal services at St James's University Hospital and Leeds General Infirmary.

Getty images

Two Leeds maternity units downgraded after inspection

The NHS regulator has downgraded two hospitals in Leeds to "inadequate" from "good" following an inspection.

The Care Quality Commission (CQC) said the maternity and neonatal services at Leeds General Infirmary (LGI) and St James' University Hospital of the Leeds Teaching Hospitals (LTH) NHS Trust posed "a significant risk" to women and babies.

Keep ReadingShow less
Community Pharmacy England (CPE) chief executive Janet Morrison was one of the signatories of the statement

Community Pharmacy England (CPE) chief executive Janet Morrison was one of the signatories of the statement

Primary care leaders join forces in effort to 'transform investment into primary care'

Community Pharmacy England (CPE) has teamed up with other national primary care bodies to urge the government to allocate more funds towards the sector.

In a joint statement released on the back of the government’s spending review, last week, the organisations welcomed the government’s continued determination to ‘shift care from hospitals to community and from sickness to prevention’ but warned that this would not be possible ‘without further investment in primary care’.

Keep ReadingShow less
Cancer patients warned against using weight-loss jabs

Macmillan Cancer Support said there is not enough evidence on how the weight-loss jabs might affect anti-cancer treatments.

iStock

Cancer patients warned against using weight-loss jabs

Cancer patients have been advised to consult their doctor before taking any weight-loss jabs.

Macmillan Cancer Support has issued this advisory following a surge in calls by cancer patients asking whether they can take fat loss jabs such as Wegovy and Mounjaro.

Keep ReadingShow less
Kamson Pharmacy to deliver more clinical services after installing hub and spoke technology

The FLOWRx auto hub in the new Kamson warehouse in Uckfield.

Kamson Pharmacy to deliver more clinical services after installing hub and spoke technology


Kamsons Pharmacy has announced that it has implemented a state-of-the-art hub and spoke dispensing model with the aim of freeing up more time to deliver clinical services.

Keep ReadingShow less
RPS group aims to tackle barriers holding back black pharmacy students

Work is underway to improve inclusivity in teaching

Pic credit: iStock

RPS group aims to tackle barriers holding back black pharmacy students

A cross-sector group aimed at tackling barriers that block the progression of black students and trainee pharmacists held its first meeting this week.

The Royal Pharmaceutical Society (RPS) has created the Differential Attainment Oversight Group to address issues that black or black British African student pharmacists and foundation trainees face such as limited access to work experience, financial support and visible role models in education and training.

Keep ReadingShow less